We are live on ! Find out more
AZNH

AstraZeneca
AZNH

Delisted

AZNH was delisted on the 29th of January, 2026.

Back to rankings

1 hedge funds and large institutions have $4.02M invested in AstraZeneca in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more capital invested

Capital invested by funds: $2.09M → $4.02M (+$1.93M)

36.1% more ownership

Funds ownership: 50.91% → 87.01% (+36%)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.64M

Top Sellers

No sellers this quarter

AZNH Hedge Fund Activity: Q3 2025 in Review

1 of the 7,646 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q3 2025, worth a combined $4.02M — up 93% from $2.09M a quarter earlier.

Fund positioning in AZNH was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $1.64M.

  • 1 institutional investor held AstraZeneca (AZNH) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $4.02M of AstraZeneca stock for Q3 2025, up 93% quarter-over-quarter.
  • 0 funds opened new AstraZeneca positions in Q3 2025 and 0 closed out.
  • The largest AstraZeneca buyer in Q3 2025 was Citadel Advisors, an estimated $1.64M added.

Based on aggregated 13F filings for Q3 2025.